A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
about
Gender analysis of moxifloxacin clinical trialsRecommendations and rationale for the treatment of pelvic inflammatory disease.Sexually transmitted diseases treatment guidelines, 2015.2012 European guideline for the management of pelvic inflammatory disease.Controversies in family planning: postabortal pelvic inflammatory disease.Antibiotic therapy for pelvic inflammatory disease.A new paradigm for clinical trials in antibiotherapy?2017 European guideline for the management of pelvic inflammatory disease.
P2860
Q28538319-AFE4BA59-8495-4671-8251-F92CD060D017Q34155769-DAA92346-6B03-47D2-8A45-BA36EC461CEDQ34479272-323AED24-BBDD-4A0A-BBDF-9F39D63EBB59Q34657350-51CB37C3-2DE0-4E20-A4F1-61F878F9AB81Q37098257-9E87ADCC-D0B0-4241-BCE9-9C0A4CDDF50AQ37834340-B2F2C416-B2B5-4199-96D7-FB47FF6FE82CQ42838869-2DABB104-061B-483A-BF63-957F15BE4377Q49342581-5B122C66-AF68-43C2-906A-BB18C0A62F16
P2860
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A randomized double-blind comp ...... d pelvic inflammatory disease.
@en
A randomized double-blind comp ...... d pelvic inflammatory disease.
@nl
type
label
A randomized double-blind comp ...... d pelvic inflammatory disease.
@en
A randomized double-blind comp ...... d pelvic inflammatory disease.
@nl
prefLabel
A randomized double-blind comp ...... d pelvic inflammatory disease.
@en
A randomized double-blind comp ...... d pelvic inflammatory disease.
@nl
P2093
P2860
P356
P1476
A randomized double-blind comp ...... d pelvic inflammatory disease.
@en
P2093
J D C Ross
PID Study Group
P2860
P304
P356
10.1258/IJSA.2008.008495
P577
2009-10-01T00:00:00Z